Microbot Medical Inc. announced on June 30, 2025, that it was officially added as a member of the Russell Microcap® Index. This inclusion became effective today when the U.S. equity markets opened.
Chairman, CEO, and President Harel Gadot stated that inclusion in the Russell Microcap® Index marks another important milestone for Microbot Medical. He noted it reflects the strong execution of the team and the momentum built, including ongoing interaction with the FDA on the 510(k) submission for LIBERTY.
Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. This enhances the company's visibility at a pivotal time as it continues to prepare for its anticipated Q3 launch.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.